Timothy Van Hauwermeiren
CIK 1816206 · last filed 2026-06-05
Timothy Van Hauwermeiren is a corporate insider who has filed 13 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for DNLI, was dated Jun 5, 2026. Current disclosed insider exposure totals $369.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$369.1K
4
13
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNLI | Director | 17,040 | $21.66 | $369.1K | $0 | 2 | 2026-06-05 |
| LXEO | Director | — | $4.37 | — | $0 | 2 | 2025-06-30 |
| iTeos Therapeutics, Inc. (ITOS) Delisted | Director | 22,346 | $10.15 | $226.8K | $0 | 7 | 2025-05-14 |
| RayzeBio, Inc. (RYZB) Delisted | Director | — | $62.49 | — | $0 | 2 | 2024-02-27 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | DNLI | Grant (A) | +6,408 | $0 | EDGAR |
| 2025-11-06 | DNLI | Grant (A) | +10,632 | $0 | EDGAR |
| 2025-06-30 | LXEO | Grant (A) | — | $0 | EDGAR |
| 2025-05-14 | iTeos Therapeutics, Inc. (ITOS) Delisted | Exer (M) | +22,346 | $96.1K | EDGAR |
| 2024-07-08 | LXEO | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-27 | RayzeBio, Inc. (RYZB) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-11-01 | RayzeBio, Inc. (RYZB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |